| Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis V Rotshild, B Hirsh-Raccah, I Miskin, M Muszkat, I Matok Scientific reports 11 (1), 22777, 2021 | 232 | 2021 |
| Fluoroquinolones and cardiovascular risk: a systematic review, meta-analysis and network meta-analysis E Gorelik, R Masarwa, A Perlman, V Rotshild, M Abbasi, M Muszkat, ... Drug safety 42, 529-538, 2019 | 111 | 2019 |
| Systematic review, meta-analysis, and network meta-analysis of the cardiovascular safety of macrolides E Gorelik, R Masarwa, A Perlman, V Rotshild, M Muszkat, I Matok Antimicrobial agents and chemotherapy 62 (6), 10.1128/aac. 00438-18, 2018 | 68 | 2018 |
| Investigation of the enhancing mechanism of sodium N-[8-(2-hydroxybenzoyl) amino] caprylate effect on the intestinal permeability of polar molecules utilizing a voltage clamp … S Hess, V Rotshild, A Hoffman European journal of pharmaceutical sciences 25 (2-3), 307-312, 2005 | 45 | 2005 |
| The risk for lung cancer incidence with calcium channel blockers: a systematic review and meta-analysis of observational studies V Rotshild, L Azoulay, M Zarifeh, R Masarwa, B Hirsh-Raccah, A Perlman, ... Drug Safety 41, 555-564, 2018 | 38 | 2018 |
| Calcium channel blockers and the risk for lung cancer: a population-based nested case-control study V Rotshild, L Azoulay, I Feldhamer, A Perlman, M Glazer, M Muszkat, ... Annals of Pharmacotherapy 53 (5), 445-452, 2019 | 20 | 2019 |
| Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate-or high-risk pulmonary embolism: systematic review and … D Planer, S Yanko, I Matok, O Paltiel, R Zmiro, V Rotshild, O Amir, ... CMAJ 195 (24), E833-E843, 2023 | 17 | 2023 |
| Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors and the risk for neurocognitive adverse events: A systematic review, meta-analysis and meta-regression BH Raccah, A Yanovsky, N Treves, V Rotshild, C Renoux, H Danenberg, ... International Journal of Cardiology 335, 7-14, 2021 | 14 | 2021 |
| Empiric treatment with once-daily cefonicid and gentamicin for febrile non-neutropenic pediatric cancer patients with indwelling central venous catheters D Averbuch, R Makhoul, V Rotshild, M Weintraub, D Engelhard Journal of Pediatric Hematology/Oncology 30 (7), 527-532, 2008 | 14 | 2008 |
| Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis. Sci Rep. 2021; 11 (1): 22777 V Rotshild, B Hirsh-Raccah, I Miskin, M Muszkat, I Matok | 10 | |
| Calcium channel blocker use and the risk for breast cancer: a population-based nested case-control study V Rotshild, B Hirsh Raccah, M Gazawe, I Matok Cancers 14 (9), 2344, 2022 | 9 | 2022 |
| Calcium channel blocker use and the risk for prostate cancer: a population‐based nested case‐control study V Rotshild, L Azoulay, I Feldhamer, A Perlman, M Muszkat, I Matok Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (6 …, 2019 | 9 | 2019 |
| Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: Systematic review and network meta-analysis M Zur, T Peselev, S Yanko, V Rotshild, I Matok Antiviral Research, 105768, 2023 | 7 | 2023 |
| The risk for prostate cancer with calcium channel blockers: a systematic review, meta-analysis, and meta-regression V Rotshild, N Rabkin, I Matok Annals of Pharmacotherapy 57 (1), 16-28, 2023 | 7 | 2023 |
| Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis. Sci. Rep. 11, 22777 V Rotshild, B Hirsh-Raccah, I Miskin, M Muszkat, I Matok | 6 | 2021 |
| Assessing cardiovascular risk factors among patients living with HIV/AIDS-survey of patients treated at the Hadassah Aids Center, Hadassah Ein Kerem, Jerusalem V Rotshild, K Olshtain-Pops, S Maayan Harefuah 152 (4), 211-5, 247, 2013 | 5 | 2013 |
| Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis. Sci Rep 2021; 11: 22777 V Rotshild, B Hirsh-Raccah, I Miskin, M Muszkat, I Matok Springer Nature or its licensor (eg a society or other partner) holds …, 0 | 5 | |
| Trends in pregabalin use and prescribing patterns in the adult population: a 10-Year Pharmacoepidemiologic Study N Benassayag Kaduri, R Dressler, W Abu Ahmad, V Rotshild CNS drugs 38 (2), 153-162, 2024 | 4 | 2024 |
| Comment on Rotshild et al's" The Risk for Prostate Cancer With Calcium Channel Blockers". KF Liao, BF Hwang, CS Liu, SW Lai Annals of Pharmacotherapy 58 (4), 2024 | 1 | 2024 |
| Authors Reply to Comment on Rotshild et al's" The Risk for Prostate Cancer With Calcium Channel Blockers". V Rotshild, I Matok Annals of Pharmacotherapy 58 (4), 2024 | | 2024 |
